Objective-The Wnt/β-catenin signaling pathway has been implicated in human heart valve disease and is required for early heart valve formation in mouse and zebrafish. However, the specific functions of Wnt/β-catenin signaling activity in heart valve maturation and maintenance in adults have not been determined previously. Approach and Results-Here, we show that Wnt/β-catenin signaling inhibits Sox9 nuclear localization and proteoglycan expression in cultured chicken embryo aortic valves. Loss of β-catenin in vivo in mice, using Periostin(Postn)Cre-mediated tissue-restricted loss of β-catenin (Ctnnb1) in valvular interstitial cells, leads to the formation of aberrant chondrogenic nodules and induction of chondrogenic gene expression in adult aortic valves. These nodular cells strongly express nuclear Sox9 and Sox9 downstream chondrogenic extracellular matrix genes, including Aggrecan, Col2a1, and Col10a1. Excessive chondrogenic proteoglycan accumulation and disruption of stratified extracellular matrix maintenance in the aortic valve leaflets are characteristics of myxomatous valve disease. Both in vitro and in vivo data demonstrate that the loss of Wnt/β-catenin signaling leads to increased nuclear expression of Sox9 concomitant with induced expression of chondrogenic extracellular matrix proteins. Conclusions-β-Catenin limits Sox9 nuclear localization and inhibits chondrogenic differentiation during valve development and in adult aortic valve homeostasis. (Arterioscler Thromb Vasc Biol. 2014;34:2601-2608.) (S.J.C.). The online-only Data Supplement is available with this article at http://atvb.ahajournals.org/lookup/suppl/
A dult heart valves are stratified into extracellular matrix (ECM) compartments, defined as collagen-rich fibrosa, proteoglycan-rich spongiosa, and elastin-rich ventricularis/ atrialis layers. 1 In diseased heart valves, disruption of ECM layers and deposition of abnormal matrix leads to valve dysfunction. Myxomatous valve disease is characterized by excessive proteoglycan accumulation and degradation of collagen and elastin fibers, leading to valve prolapse and insufficiency. [1] [2] [3] [4] The proteoglycan-rich spongiosa is similar to the ECM of cartilage, and regulatory pathways that control chondrogenesis also are active in valve development. 1, 5, 6 Although dysregulation and reactivation of early developmental programs has been described in heart valve disease, [7] [8] [9] [10] [11] it remains unclear whether the expansion of proteoglycan-rich spongiosa in myxomatous valve disease is an active chondrogenic process.
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During the initiation of heart valve development, Wnt/βcatenin signaling is required for early endocardial cushion formation. 12, 13 At later stages, Wnt/β-catenin promotes the expression of fibrosa-related and osteogenic-like ECM genes in cultured chicken embryo valvular interstitial cells (VICs). 14 Wnt/β-catenin signaling is active in normal heart valves in mice at 1 month of age and is also increased in human calcific aortic valve (AoV) disease. 14, 15 Together, these data suggest that Wnt/β-catenin signaling has multiple roles in valve development and disease. However, the specific regulatory requirements for Wnt/β-catenin signaling in valvular ECM stratification and maintenance have not been reported previously. 1, 6 Sox9, a SRY transcription factor required for cartilage lineage development, [16] [17] [18] is crucial for normal valve formation and promotes expression of cartilage-associated genes. 19, 20 In addition, Sox9 is required to prevent calcification in adult AoVs. 21, 22 In diseased human and mouse heart valves, 10, 11, 23, 24 expression of Sox9 and cartilage-related genes is induced, suggesting that induction of a chondrogenic gene program contributes to heart valve disease. In endochondral bone development, Wnt/β-catenin signaling inhibits Sox9-driven chondrogenesis and promotes osteogenic differentiation. 25 However, whether reduction of Wnt/β-catenin signaling directly promotes Sox9-mediated proteoglycan expansion in normal heart valves or in myxomatous valve disease remains untested.
Here, we used embryonic chicken aortic valve organ culture (aVOCs) to investigate the role of Wnt/β-catenin signaling in layer-specific ECM expression during valve stratification. In vivo, we used VIC-specific loss of β-catenin driven by PostnCre 26 in mice to determine requirements for β-catenin in valve ECM maturation and adult homeostasis. We show that Wnt/β-catenin limits Sox9 nuclear localization and inhibits chondrogenic differentiation of aortic VIC during heart valve development and maintenance in adults. Moreover, loss of β-catenin in mice leads to the formation of hypertrophic nodules with excessive proteoglycan accumulation in adult AoV leaflets, and similarly increased nuclear localization of Sox9 and proteoglycan expression are observed in human myxomatous valve disease.
Materials and Methods
Materials and Methods are available in the online-only Data Supplement.
Results

Wnt/β-Catenin Signaling Inhibits Chondrogenic Gene Expression in Cultured Chicken AoVs
Previously, we reported that Wnt3a treatment induces early osteogenic gene induction in cultured-dissociated chicken embryonic day (E)14 aortic VICs. 14 However, these dissociated cells do not retain the structural architecture of stratified heart valve leaflets, and therefore ECM compartmentalization cannot be examined using this method. To analyze diversified ECM production and regulation in a more physiological context, a novel aVOC system was devised. Whole AoVs including adjacent aortic root were isolated from E14 chicken embryos and cultured in vitro as aVOCs. Although valve morphology is abnormal in cultured aVOCs, ECM compartmentalization is maintained, as shown by Movat's pentachrome staining of proteoglycans, collagen fibers, and elastin, as well as immunostaining for elastin (ventricularis), Aggrecan and Collagen 2 (Col2; spongiosa), and also Col3 (fibrosa; Figure  IA -ID in the online-only Data Supplement). Thus, this system can be used for examination of regulatory mechanisms that control ECM compartmentalization in developing valves.
The role of Wnt/β-catenin signaling in heart valve ECM composition and compartmentalization was examined using the E14 chicken aVOC cultures. Cultures were treated with BIO to increase Wnt/β-catenin signaling, 27 or XAV-939 to decrease Wnt/β-catenin signaling. 28 When treated with BIO (Wnt activation), the proteoglycan-expressing area, as indicated by Alcian Blue staining, decreases compared with vehicle-treated controls (DMSO [dimethyl sulfoxide]; Figure II in the online-only Data Supplement). Although the area of proteoglycan expression was not increased in XAV-939-treated cultures, increased intensity of Alcian Blue staining was noted ( Figure IIC in the online-only Data Supplement). In contrast, XAV-939 treatment, but not BIO, decreases the fibrillar collagen-expressing area in cultured aVOC as indicated by Saffron staining ( Figure II in the online-only Data Supplement). Thus, Wnt/β-catenin signaling inhibits proteoglycan expression (spongiosa) and is required for collagen expression (fibrosa) in cultured aVOCs. Immunostaining for the chondrogenic transcription factor Sox9 demonstrates that Sox9 protein expression is decreased in cultured aVOCs with BIO treatment, whereas XAV-939 addition promotes Sox9 expression and nuclear localization ( Figure 1A-1C ). Expression of cartilage matrix proteins Aggrecan and Col2 also are repressed by BIO ( Figure 1E and 1H) and increased with XAV-939 ( Figure 1F and 1I). Quantification of gene expression by quantitative reverse transcription polymerase chain reaction confirms Wnt activation with BIO treatment, as indicated by increased Axin2 gene expression. Likewise, BIO treatment dampens Col2a1 expression but has no apparent effect on Sox9, Col10, or Aggrecan gene expression levels. By contrast, Wnt inhibition with XAV-939 induces chondrogenic markers Sox9 and Aggrecan, but not Col2a1 ( Figure 1J ). The differing effects of altered Wnt signaling on chondrogenic protein versus mRNA expression support complex downstream transcriptional and post-transcriptional regulatory mechanisms. However, together, these data support a role for Wnt/β-catenin in ECM compartmentalization by limiting nuclear localization of Sox9 and expression of chondrogenic matrix proteins.
Loss of β-Catenin in Aortic VICs Results in the Formation of Proteoglycan-Rich Nodules in Adult Mice
The role of Wnt/β-catenin signaling in adult valves in vivo was examined in mice with loss of β-catenin in VICs. Wnt/β-catenin signaling is active in semilunar valves before birth as previously reported, 14 and also at 2 weeks and in adult AoVs as indicated by an Axin2 lacZ/+ reporter line 29 (Figure 2A ; Figure III in the online-only Data Supplement). Interestingly, Wnt/β-catenin signaling is active preferentially at the distal tip and the hinge of the AoV at 2 weeks after birth and also in adult mice. PostnCre 26 was used for conditional recombination of floxed exons 2 to 6 in the β-catenin allele 30 (Ctnnb1 fl/fl ) and is active in AoV interstitial cells but not endothelium, as indicated by positive X-gal staining in adult PostnCre;ROSA26 mice ( Figure IVB in the online-only Data Supplement). 31 The efficacy of PostnCre-mediated loss of β-catenin protein was determined in semilunar valves of PostnCre;Ctnnb1 fl/fl mice at postnatal day (P)0 and 2 weeks of age. β-Catenin protein expression is reduced in the AoV interstitium, but not endothelium, of PostnCre;Ctnnb1 fl/fl mice at P0 and is not detectable at 2 weeks, compared with Cre-negative controls ( Figure with 100% penetrance at 3 months ( Figure 2B ). Cre-mediated recombination occurs throughout the valve leaflets, as apparent in PostnCre;Ctnnb1 fl/fl ;ROSA26lacZ reporter mice at 3 months ( Figure 2B ). However, the nodules are restricted to the distal tip of the AoV leaflet where Wnt/β-catenin signaling is active, as indicated by Axin2 lacZ expression ( Figure 2A ). The formation of proteoglycan-rich nodules is specific to the semilunar valves with a lower frequency of nodule formation in the pulmonary valve and no apparent abnormalities noted in the mitral or tricuspid valves in PostnCre;Ctnnb1 fl/fl animals ≤6 months of age ( Figure VII in the online-only Data Supplement).
To visualize the morphology and stratification of the AoV, Movat's pentachrome and Masson's trichrome staining were performed. In controls, the AoV is stratified with defined layers of proteoglycans and collagen ( Figure 2C and 2E ). However, all 3-month-old PostnCre;Ctnnb1 fl/fl mice exhibit large nodules almost exclusively in the distal tip of the AoV (Figure 2D and 2F). These nodules in PostnCre;Ctnnb1 fl/fl AoVs are densely stained by Alcian Blue, indicating strong proteoglycan deposition ( Figure 2D ). By contrast, fibrillar collagen deposition is apparently reduced in the nodules ( Figure 2F ), but accumulation is obvious surrounding the nodules, as indicated by Masson's trichrome staining. Strikingly, the nodular cells also exhibit dramatic morphological changes including the presence of hypertrophic cells (Figure 2B , 2D, and 2F). However, cell death was not apparent in the nodules of PostnCre;Ctnnb1 fl/fl animals, as indicated by cleaved caspase-3 immunoreactivity ( Figure VIII in the online-only Data Supplement). In addition, the PostnCre;Ctnnb1 fl/fl nodules do not calcify at 1 year of age (data not shown). The increased proteoglycan deposition and hypertrophic cellular morphology of the nodular cells in PostnCre;Ctnnb1 fl/fl AoVs at 3 months are similar to hypertrophic chondrocytes. 18 Thus, β-catenin is required for normal ECM maintenance, and loss of β-catenin leads to the formation of hypertrophic cartilagelike nodules in the adult AoV.
AoV Nodules Express Chondrogenic Genes as a Result of Loss of β-Catenin
Spongiosa and fibrosa ECM compartmentalization, as well as induction of chondrogenic regulatory mechanisms, were examined in PostnCre;Ctnnb1 fl/fl AoV nodules. Sox9 is required for chondrogenesis, 18 and for the expression of hyaluronan and proteoglycan link protein 1 (Hapln1) in developing heart valves. 32, 33 Hapln1 is normally restricted to the ventricularis side of Cre-negative control AoVs ( Figure 3A and 3C), but its expression is expanded throughout the proteoglycan-rich nodules in PostnCre;Ctnnb1 fl/fl AoVs, as detected by immunofluorescent staining (Figure 3B and 3C) . Likewise, the transcription factor Sox9 is strongly expressed in the nuclei of nodular cells at the distal tip of AoV in PostnCre;Ctnnb1 fl/fl animals ( Figure 3B and 3C) , and the percentage of Sox9positive nuclei is higher in the nodules compared with either perinodular areas or entire AoV leaflets in Cre-negative controls ( Figure 3D) Figure 4B and 4E) , in contrast to no detectable expression in the distal tip of AoV in Cre-negative controls ( Figure 4A and 4D). Consistent with the morphology similar to hypertrophic cartilage ( Figure 2F and 2H) , the nodular cells in PostnCre;Ctnnb1 fl/fl AoVs also express ColX ( Figure 4H ), which is a hypertrophic chondrocyte marker 18 and is not normally expressed in heart valves ( Figure 4G ). Likewise, quantitative reverse transcription polymerase chain reaction analysis of gene expression demonstrates that Acan is increased by 33-fold ( Figure 4C) , Col2a1 by ≈260-fold ( Figure 4F The proteoglycan composition and timing of induction were further examined in PostnCre;Ctnnb1 fl/fl AoVs. Versican (Vcan) is normally the predominant proteoglycan in the spongiosa layer of AoVs ( Figure 4J ), but is dramatically reduced in the nodules of PostnCre;Ctnnb1 fl/fl AoVs, demonstrating a switch in the predominant proteoglycan to Aggrecan, with loss of β-catenin ( Figure 4K) . Consistent with the transition to a chondrogenic ECM, the expression of Hapln1 expands markedly to encompass the entire nodule in PostnCre;Ctnnb1 fl/fl AoVs ( Figure 4K ). Quantitative reverse transcription polymerase chain reaction analysis also demonstrates that Hapln1 is increased by 8-fold and Vcan is decreased by 60% ( Figure 4L ). The initiation of nodule formation and proteoglycan alterations were examined at early postnatal stages. At P0 and 2 weeks, Aggrecan, not normally expressed in mouse AoVs, is detected in PostnCre;Ctnnb1 fl/fl AoVs ( Figure XB and XD in the online-only Data Supplement). Other chondrogenic ECM markers, including Col2 and ColX, are not expressed in PostnCre;Ctnnb1 fl/fl AoV at this early stage, indicating that formation of the hypertrophic nodules develops over time. Thus, the loss of β-catenin leads to induction of proteoglycans and collagens characteristic of cartilage, beginning with Aggrecan. Together, these data suggest that loss of β-catenin drives VICs in PostnCre;Ctnnb1 fl/fl AoVs to undergo progressive chondrogenic differentiation and maturation after birth.
Fibrosa ECM Is Dysregulated in Adult AoV Lacking β-Catenin
The initial formation and compartmentalization of the fibrosa layer relative to the spongiosa was examined in PostnCre;Ctnnb1 fl/fl AoVs at P0 and 2 weeks. The initial organization of collagen and proteoglycan-rich regions of semilunar valves is apparently normal, as indicated by Movat's pentachrome staining ( Figure VIE and VIF in the online-only Data Supplement). Localized expression of Col1 and Hapln1 also is apparently normal at 2 weeks in both PostnCre;Ctnnb1 fl/fl animals and Cre-negative controls ( Figure XG and XH in the online-only Data Supplement). In adult mice, Col1 expression normally is restricted to the fibrosa layer ( Figure 5A ). However, this well-defined layer is lost in PostnCre;Ctnnb1 fl/fl AoVs, in which Col1 is absent from the nodules but is apparent in the perinodular areas ( Figure 5B ). Likewise, Col3 is predominantly expressed in the fibrosa layer in Cre-negative control AoVs ( Figure 5C ). However, in PostnCre;Ctnnb1 fl/fl AoVs, Col3 expression is expanded throughout the thickened leaflets but is only minimally expressed in the proteoglycanrich nodules ( Figure 5D ). Consistent with the expression of Col1 and Col3, endogenous Postn is not detected within the nodules of PostnCre;Ctnnb1 fl/fl animals but is expressed in the thickened distal tip in the collagen-rich region ( Figure 5E and 5F). In addition, Col1a1 and Postn transcripts are significantly decreased in PostnCre;Ctnnb1 fl/fl AoVs, compared with Crenegative controls ( Figure 5G) , at 3 months. Thus, the proteoglycan-rich nodules lose the expression of fibrillar collagens and matricellular Postn, whereas the fibrosa layer is disrupted in adult PostnCre;Ctnnb1 fl/fl AoVs. Together, these data demonstrate that the loss of β-catenin signaling disrupts normal ECM maintenance and compartmentalization in the adult AoV.
Discussion
β-Catenin is required for endothelial-to-mesenchymal transition at the early endocardial cushion stage in heart valve development, 13 and upregulation of Wnt/β-catenin signaling has been implicated in heart valve disease. 15 Here, we show that β-catenin signaling is required for normal ECM maintenance and heart valve homeostasis in cultured embryonic chicken AoVs and adult mice. In vitro and in vivo analyses demonstrate increased nuclear localization of Sox9 and Embryonic aVOC cultures treated with the Wnt/β-catenin activator BIO have decreased proteoglycan deposition, whereas treatment with the inhibitor XAV leads to increased chondrogenic matrix protein expression and nuclear localization of Sox9. Likewise, the treatment of isolated embryonic aortic VICs with Wnt3a induces fibrosa-like gene expression consistent with a role in heart valve ECM compartmentalization. 14 However, the initial stratification of PostnCre;Ctnnb1 fl/fl AoVs is normal at 2 weeks of age, indicating that Wnt/βcatenin signaling is not required for initiation of valve stratification, but rather for maintenance of normal ECM compartmentalization. Further evidence for active Wnt/βcatenin signaling in adult valve homeostasis is the expression of a Axin2 lacZ/+ reporter in the distal regions of adult AoV and reduction of Axin2 transcripts in PostnCre;Ctnnb1 fl/fl AoVs. Interestingly, the formation of hypertrophic cartilage-like nodules in PostnCre;Ctnnb1 fl/fl mice also occurs at the distal tips of the AoVs. The lack of an initial effect on valve stratification and the localization of the chondrogenic nodules to the distal tips of the AoV leaflets in PostnCre;Ctnnb1 fl/fl mice is in contrast to the results observed in cultured embryonic aVOCs and suggests that Wnt/β-catenin signaling is modulated by physiological factors in vivo. It has been reported that mechanical tension and compression stimulate the expression of Wnt10b, and coreceptor Lrp5 in cultured osteoblast cells. 34 The intracellular mechanosensing RhoA/ROCK cascade also affects Sox9 expression and activity. 35, 36 Thus, mechanical stimulation may have a role in the interaction between Wnt/βcatenin signaling and Sox9-mediated chondrogenic differentiation in the aortic VICs.
Loss of β-catenin in VICs leads to increased expression and nuclear localization of Sox9, as well as increased expression of Col2a1, Acan, and Col10a1, in cultured aVOC and adult AoVs. This same regulatory hierarchy is active in hypertrophic cartilage, [37] [38] [39] and loss of β-catenin in mesenchymal progenitors leads to increased expression of Sox9 and ectopic cartilage formation in the developing skull. 40, 41 Here, we demonstrate that the loss of Wnt/β-catenin signaling leads to increased nuclear localization of Sox9 and chondrogenic gene induction in valve progenitors and adult valves. Although Sox9 and β-catenin proteins have been demonstrated to interact in cartilage 39, 42 and gonad development, 43 the mechanism by which loss of β-catenin leads to increased nuclear localization of Sox9 is not known. In developing valves, Sox9 is required for expression of cartilage-related ECM genes, including Hapln1 and Col2a1. 20 Haploinsufficiency of Sox9 in heart valves is sufficient to promote ectopic calcification in adult mice, 21 and Sox9 suppresses Osteopontin expression preventing matrix mineralization in postnatal mouse heart valve explants. 22 Increased Wnt/β-catenin signaling has also been implicated in human calcific AoV disease, potentially by promoting active osteogenesis in the fibrosa layer. 15, 44 Here, we show that the loss of β-catenin leads to abnormal chondrogenic differentiation of aortic VICs with excessive accumulation of proteoglycans in mice. Likewise, nuclear Sox9 and Hapln1 protein expression are increased in human myxomatous valve disease. Together, these data provide further evidence for shared regulatory mechanisms in skeletal lineages and in heart valve development and disease. 1,5,6 Excessive proteoglycan accumulation is one of the characteristics of myxomatous valve disease. [1] [2] [3] [4] Although its cause seems complex, mutations in the cytoskeletal protein Filamin A (FLNA) and a variety of ECM protein mutations have been linked to human myxomatous valve disease. 2, 3, [45] [46] [47] Additional causes include congenital malformation, increased serotonin signaling, or infective endocarditis. 48 In each case, the myxomatous valve exhibits increased proteoglycan and decreased collagen composition leading to insufficiency and regurgitation. However, the molecular mechanism(s) of disease pathogenesis and progression are still poorly understood. 3, 4 Expression of Aggrecan, Col2, and Sox9 is induced in human myxomatous valve disease, suggesting that chondrogenic differentiation of VICs is integral to disease pathogenesis. 24 Similarly, in mice lacking endogenous Postn, inappropriate differentiation of mesenchymal cushion cells and abnormal Aggrecan expression were detected in Postn −/− valves. 49 Here, we demonstrate that VICs directly undergo chondrogenic differentiation with excessive proteoglycan accumulation as a result of loss of β-catenin. The chondrogenic nodules observed in mouse AoVs are not a characteristic feature of human valve pathology. However, predominant nuclear Sox9 localization in regions of increased Hapln1 protein expression was observed in both PostnCre;Ctnnb1 fl/fl AoV and human myxomatous mitral valve disease, supporting a role for this regulatory interaction in human valve pathogenesis. It remains to be determined whether Wnt/β-catenin signaling is repressed by the multiple causes of myxomatous valve disease or contributes to pathogenesis that ultimately leads to valve insufficiency. If this is the case, maintaining or increasing Wnt/β-catenin signaling could be exploited therapeutically as an alternative to surgical repair, which is the current standard of care for severe myxomatous valve disease. 3 
